Androgen suppresses PML protein expression in prostate cancer CWR22R cells

Lin Yang, Shauh Der Yeh, Shaozhen Xie, Saleh Altuwaijri, Jing Ni, Yueh Chiang Hu, Yen Ta Chen, Bo Ying Bao, Ching-Hua Su, Chawnshang Chang

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The ability of PML to modulate key suppressive pathways in tumor cells suggests that PML may act as a tumor suppressor. The detailed mechanism of how PML functions in prostate cancer progression, however, remains unknown. Here we demonstrate that in the presence of androgen, PML protein expression can be suppressed in CWR22R prostate cancer cells. Further studies reveal that PML can selectively suppress AR transactivation and PML protein expression positively correlates with increased p21 protein level and enhances p53 transcription ability in CWR22R cells. We also found that PML strongly inhibits CWR22R cell colony formation, while PML siRNA enhances AR activity and CWR22R cell colony formation. Together our results suggest that PML may suppress prostate cancer cell growth by inhibiting AR transactivation and/or enhancing p53 activity.

Original languageEnglish
Pages (from-to)69-75
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume314
Issue number1
DOIs
Publication statusPublished - Jan 30 2004

Fingerprint

Androgens
Prostatic Neoplasms
Tumors
Cells
Proteins
Cell growth
Transcription
Small Interfering RNA
Transcriptional Activation
Neoplasms
Growth

Keywords

  • Androgen receptor
  • CWR22R
  • PML

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Androgen suppresses PML protein expression in prostate cancer CWR22R cells. / Yang, Lin; Yeh, Shauh Der; Xie, Shaozhen; Altuwaijri, Saleh; Ni, Jing; Hu, Yueh Chiang; Chen, Yen Ta; Bao, Bo Ying; Su, Ching-Hua; Chang, Chawnshang.

In: Biochemical and Biophysical Research Communications, Vol. 314, No. 1, 30.01.2004, p. 69-75.

Research output: Contribution to journalArticle

Yang, L, Yeh, SD, Xie, S, Altuwaijri, S, Ni, J, Hu, YC, Chen, YT, Bao, BY, Su, C-H & Chang, C 2004, 'Androgen suppresses PML protein expression in prostate cancer CWR22R cells', Biochemical and Biophysical Research Communications, vol. 314, no. 1, pp. 69-75. https://doi.org/10.1016/j.bbrc.2003.12.060
Yang, Lin ; Yeh, Shauh Der ; Xie, Shaozhen ; Altuwaijri, Saleh ; Ni, Jing ; Hu, Yueh Chiang ; Chen, Yen Ta ; Bao, Bo Ying ; Su, Ching-Hua ; Chang, Chawnshang. / Androgen suppresses PML protein expression in prostate cancer CWR22R cells. In: Biochemical and Biophysical Research Communications. 2004 ; Vol. 314, No. 1. pp. 69-75.
@article{6ee24d40a60445ae96fc3f65322d0959,
title = "Androgen suppresses PML protein expression in prostate cancer CWR22R cells",
abstract = "The ability of PML to modulate key suppressive pathways in tumor cells suggests that PML may act as a tumor suppressor. The detailed mechanism of how PML functions in prostate cancer progression, however, remains unknown. Here we demonstrate that in the presence of androgen, PML protein expression can be suppressed in CWR22R prostate cancer cells. Further studies reveal that PML can selectively suppress AR transactivation and PML protein expression positively correlates with increased p21 protein level and enhances p53 transcription ability in CWR22R cells. We also found that PML strongly inhibits CWR22R cell colony formation, while PML siRNA enhances AR activity and CWR22R cell colony formation. Together our results suggest that PML may suppress prostate cancer cell growth by inhibiting AR transactivation and/or enhancing p53 activity.",
keywords = "Androgen receptor, CWR22R, PML",
author = "Lin Yang and Yeh, {Shauh Der} and Shaozhen Xie and Saleh Altuwaijri and Jing Ni and Hu, {Yueh Chiang} and Chen, {Yen Ta} and Bao, {Bo Ying} and Ching-Hua Su and Chawnshang Chang",
year = "2004",
month = "1",
day = "30",
doi = "10.1016/j.bbrc.2003.12.060",
language = "English",
volume = "314",
pages = "69--75",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier B.V.",
number = "1",

}

TY - JOUR

T1 - Androgen suppresses PML protein expression in prostate cancer CWR22R cells

AU - Yang, Lin

AU - Yeh, Shauh Der

AU - Xie, Shaozhen

AU - Altuwaijri, Saleh

AU - Ni, Jing

AU - Hu, Yueh Chiang

AU - Chen, Yen Ta

AU - Bao, Bo Ying

AU - Su, Ching-Hua

AU - Chang, Chawnshang

PY - 2004/1/30

Y1 - 2004/1/30

N2 - The ability of PML to modulate key suppressive pathways in tumor cells suggests that PML may act as a tumor suppressor. The detailed mechanism of how PML functions in prostate cancer progression, however, remains unknown. Here we demonstrate that in the presence of androgen, PML protein expression can be suppressed in CWR22R prostate cancer cells. Further studies reveal that PML can selectively suppress AR transactivation and PML protein expression positively correlates with increased p21 protein level and enhances p53 transcription ability in CWR22R cells. We also found that PML strongly inhibits CWR22R cell colony formation, while PML siRNA enhances AR activity and CWR22R cell colony formation. Together our results suggest that PML may suppress prostate cancer cell growth by inhibiting AR transactivation and/or enhancing p53 activity.

AB - The ability of PML to modulate key suppressive pathways in tumor cells suggests that PML may act as a tumor suppressor. The detailed mechanism of how PML functions in prostate cancer progression, however, remains unknown. Here we demonstrate that in the presence of androgen, PML protein expression can be suppressed in CWR22R prostate cancer cells. Further studies reveal that PML can selectively suppress AR transactivation and PML protein expression positively correlates with increased p21 protein level and enhances p53 transcription ability in CWR22R cells. We also found that PML strongly inhibits CWR22R cell colony formation, while PML siRNA enhances AR activity and CWR22R cell colony formation. Together our results suggest that PML may suppress prostate cancer cell growth by inhibiting AR transactivation and/or enhancing p53 activity.

KW - Androgen receptor

KW - CWR22R

KW - PML

UR - http://www.scopus.com/inward/record.url?scp=9144243266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144243266&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2003.12.060

DO - 10.1016/j.bbrc.2003.12.060

M3 - Article

C2 - 14715247

AN - SCOPUS:9144243266

VL - 314

SP - 69

EP - 75

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -